Cell & Gene State of the Industry Briefing

Webinar Now Available!

The webinar of ARM’s 2021 Cell & Gene State of the Industry Briefing – which took place Wednesday, January 13 – is now available below. This event is a top-level gathering for key stakeholders in the field and includes ARM’s annual yearly update on the sector’s progress followed by a panel session featuring top CEOs and executives highlighting future inflection points for cell and gene therapies in the coming year.

Speakers:

Introduction & Industry Update

Janet Lambert, CEO, Alliance for Regenerative Medicine

Panel: Looking Ahead – What to Expect for the Cell & Gene Therapy Sector in 2021 and Beyond

Terry-Ann Burrell, Chief Financial Officer, Beam Therapeutics (moderator)
Marianne De Backer,
Member of Executive Committee and EVP, Head of Strategy and Business Development & Licensing, Pharmaceuticals Division, Bayer
Sandy Macrae, President & CEO, Sangamo Therapeutics
Ken Mills, CEO, REGENXBIO
Adrian Rawcliffe, CEO, Adaptimmune

Who Attends?

Over 800 of the cell and gene therapy field’s top stakeholders watched the session live in 2021 including company founders, C-level business executives, investors, media, patient advocates and academic leaders interested in learning more on the sector’s recent advances and outlook for the industry in the coming year.

In Partnership With:

 

 

Questions?
Please contact Jeanette Lazusky at jlazusky@alliancerm.org.